|Table of Contents|

Expression and clinical significance of YAP and Src in gastric cancer tissues

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

2023 13
Research Field:
Publishing date:


Expression and clinical significance of YAP and Src in gastric cancer tissues
CAI Jiahui1TAO Fei2
1.Qinghai University,Qinghai Xining 810016,China;2.Qinghai Provincial People's Hospital,Qinghai Xining 810007,China.
gastric cancerYAPSrcimmunohistochemical
Objective:To investigate the differences in the expression of YAP and Src in tumor and adjacent tissues of patients with gastric cancer,and to analyze the relationship between the expression of YAP and Src in tumor tissues and clinicopathological features,as well as the correlation between the YAP expression and Src expression.Methods:Sixty-one patients with gastric cancer diagnosed in Qinghai Provincial People's Hospital from 2020 to 2022 were collected,and 61 cases of tumor tissues and 40 cases of adjacent tissues were collected.The expressions of YAP and Src in tumor tissues and adjacent tissues were detected by immunohistochemical method,and their expressions and correlations were analyzed.Their expressions were combined with clinicopathological data for statistical analysis.Results:The positive rates of YAP and Src expression in tumor tissues (95.1%,83.6%) were significantly higher than those in adjacent tissues (30.0%,27.5%) (all P<0.01).The expression of YAP in tumor tissues was related to the age,nationality,differentiation,infiltration depth,vascular invasion,nerve invasion and Ki67 positive index (all P<0.05).The expression of Src was correlated with nationality,tumor site,infiltration depth,nerve invasion,Ki67 positive index and HER-2 status (all P<0.05).The expression of YAP and Src in tumor tissues was positively correlated (r=0.514,P<0.01).Conclusion:YAP and Src are over-expressed in tumor tissues of patients with gastric cancer,and the expression of YAP and Src is positively correlated.The high expression of both of them is closely related to some adverse clinicopathological features of gastric cancer patients.


[1] LI Y,XU C,WANG B,et al.Author correction:Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies[J].Nat Commun,2022,13(1):6749.
[2] LI X,XU J,XIE J,et al.Research progress in targeted therapy and immunotherapy for gastric cancer[J].Chin Med J (Engl),2022,135(11):1299-1313.
[3] GIRAUD J,MOLINA-CASTRO S,SEENEEVASSEN L,et al.Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells[J].Int J Cancer,2020,146(8):2255-2267.
[4] JIAO S,GUAN J,CHEN M,et al.Targeting IRF3 as a YAP agonist therapy against gastric cancer[J].J Exp Med,2018,215(2):699-718.
[5] YONG J,LI Y,LIN S,et al.Inhibitors targeting YAP in gastric cancer:Current status and future perspectives[J].Drug Des Devel Ther,2021,15:2445-2456.
[6] CANER A,ASIK E,OZPOLAT B.SRC signaling in cancer and tumor microenvironment[J].Adv Exp Med Biol,2021,1270:57-71.
[7] LAMAR JM,XIAO Y,NORTON E,et al.SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis[J].J Biol Chem,2019,294(7):2302-2317.
[8] 中华人民共和国国家卫生健康委员会医政医管局.胃癌诊疗指南(2022年版)[J].中华消化外科杂志,2022,21(09):1137-1164. People's Republic of China (PRC) National Health and Wellness Committee Medical Administration Hospital Authority.Guidelines for diagnosis and treatment of gastric cancer (2022 edition) [J].Chinese Journal of Digestive Surgery,2022,21(09):1137-1164.
[9] 韩新影,孙杰,李艳艳,等.YAP、VGLL4蛋白在胃癌组织中的表达及对侵袭和转移的影响[J].现代肿瘤医学,2018,26(02):237-240. HAN XY,SUN J,LI YY,et al.Expression of YAP and VGLL4 proteins in gastric cancer and their effects on invasion and metastasis [J].Modern Oncology,2018,26(02):237-240.
[10] JAROENLAPNOPPARAT A,BHATIA K,COBAN S.Inflammation and gastric cancer[J].Diseases,2022,10(3):35.
[11] BIE Q,LI X,LIU S,et al.YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2[J].Int J Clin Oncol,2020,25(12):2055-2065.
[12] 杜洁,柯洋,郜辉,等.Yes相关蛋白1在胃癌组织中的表达及与患者临床特征和预后的关系[J].癌症进展,2021,19(21):2210-2213. DU J,KE Y,GAO H,et al.Expression of yes-related protein 1 in gastric cancer and its relationship with clinical characteristics and prognosis of patients [J].Journal of Cancer Progress,2021,19(21):2210-2213.
[13] IBAR C,IRVINE KD.Integration of Hippo-YAP signaling with metabolism[J].Dev Cell,2020,54(2):256-267.
[14] EHMER U,SAGE J.Control of proliferation and cancer growth by the Hippo signaling pathway[J].Mol Cancer Res,2016,14(2):127-140.
[15] LI HL,LI QY,JIN MJ,et al.A review:hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression[J].J Cancer Res Clin Oncol,2021,147(6):1569-1585.
[16] WANG EY,CHENG JC,THAKUR A,et al.YAP transcriptionally regulates ErbB2 to promote liver cell proliferation[J].Biochim Biophys Acta Gene Regul Mech,2018,1861(9):854-863.
[17] MELLO AA,LEAL MF,REY JA,et al.Deregulated expression of SRC,LYN and CKB kinases by DNA methylation and its potential role in gastric cancer invasiveness and metastasis[J].PLoS One,2015,10(10):e0140492.
[18] ZHAO L,LI X,SONG N,et al.Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT[J].Cell Biol Int,2018,42(3):294-302.
[19] VADLAMUDI RK,SAHIN AA,ADAM L,et al.Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215[J].FEBS Lett,2003,543(1-3):76-80.
[20] JIN MH,NAM AR,PARK JE,et al.Resistance mechanism against trastuzumab in HER2-positive cancer cells and its negation by Src inhibition[J].Mol Cancer Ther,2017,16(6):1145-1154.
[21] DAI Y,SIEMANN D.c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells[J].Onco Targets Ther,2019,12:3519-3529.
[22] ABUDOUKERIMU A,HASIMU A,ABUDOUKERIMU A,et al.HIF-1α regulates the progression of cervical cancer by targeting YAP/TAZ[J].J Oncol,2022,2022:3814809.
[23] 袁青玲,祁玉娟,王冬梅,等.青海地区胃癌发病危险因素的病例对照研究[J].中国现代医学杂志,2021,31(06):5-10. YUAN QL,QI YJ,WANG DM,et al.A case-control study on risk factors of gastric cancer in Qinghai [J].China Journal of Modern Medicine,2021,31(06):5-10.
[24] HSU PC,YANG CT,JABLONS DM,et al.The crosstalk between Src and Hippo/YAP signaling pathways in non-small cell lung cancer (NSCLC)[J].Cancers (Basel),2020,12(6):1361.
[25] LAMAR JM,XIAO Y,NORTON E,et al.SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis[J].J Biol Chem,2019,294(7):2302-2317.
[26] MONTENEGRO RC,HOWARTH A,CERONI A,et al.Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib[J].Oncotarget,2020,11(5):535-549.
[27] CHAIB I,KARACHALIOU N,PILOTTO S,et al.Co-activation of STAT3 and YES-associated protein 1 (YAP1) pathway in EGFR-mutant NSCLC[J].J Natl Cancer Inst,2017,109(9):djx014.


Last Update: 2023-05-31